Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
PMCB holding history
PharmaCyte Biotech, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PMCB overviewAll 13F holders of PMCBFull Q2 2026 holdings
- Shares (Q2 2026)
- 283,381
- Value
- $218.2K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 283,381 | $218.2K | <0.1% | −76,166−21.2% | Reduced | Holders |
| Q1 2026 | 359,547 | $239.2K | <0.1% | +129,825+56.5% | Added | Holders |
| Q4 2025 | 229,722 | $166.3K | <0.1% | +215,191+1,480.9% | Added | Holders |
| Q3 2025 | 14,531 | $14.1K | <0.1% | +14,531 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −8,561−100.0% | Sold out | Holders |
| Q1 2024 | 8,561 | $20.3K | <0.1% | −20,057−70.1% | Reduced | Holders |
| Q4 2023 | 28,618 | $61.8K | <0.1% | −6,766−19.1% | Reduced | Holders |
| Q3 2023 | 35,384 | $74.3K | <0.1% | −29,524−45.5% | Reduced | Holders |
| Q2 2023 | 64,908 | $185.6K | <0.1% | −11,103−14.6% | Reduced | Holders |
| Q1 2023 | 76,011 | $221.2K | <0.1% | +58,508+334.3% | Added | Holders |
| Q4 2022 | 17,503 | $51.1K | <0.1% | +17,503 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −31,696−100.0% | Sold out | Holders |
| Q2 2022 | 31,696 | $72.0K | <0.1% | +31,696 | New | Holders |